Home › Funds › ANTIPODES PARTNERS Ltd › MRK

ANTIPODES PARTNERS Ltd position in MRK

MERCK & CO · Health Care

ANTIPODES PARTNERS Ltd reported holding 904,674 shares of MRK (MERCK & CO) in its Q3 2026 13F filing — a position valued at US$131.5M, representing 2.42% of its reported portfolio and ranking #13 among its reported holdings. ANTIPODES PARTNERS Ltd has disclosed MRK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)904.67K sh
Reported value held$131.46M
Portfolio Weight2.42%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How ANTIPODES PARTNERS Ltd's MRK position evolved

ANTIPODES PARTNERS Ltd first disclosed a stake in MRK in Q3 2023 at 2,269,999 shares (US$236.8M). The position peaked in Q1 2024 at 1,889,305 shares, worth US$249.3M. Across 13 filings, ANTIPODES PARTNERS Ltd increased the stake 2 time(s), trimmed it 10 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 904,674 shares valued at US$131.5M — a reduction of -192,835 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.27M $236.76M New
Q4 2023 2.17M $237.11M Reduce
Q1 2024 1.89M $249.29M Reduce
Q2 2024 1.68M $207.44M Reduce
Q3 2024 1.58M $178.96M Reduce
Q4 2024 1.85M $183.92M Add
Q1 2025 1.97M $176.66M Add
Q2 2025 1.81M $143.63M Reduce
Q3 2025 1.67M $140.30M Reduce
Q4 2025 1.58M $165.88M Reduce
Q1 2026 1.44M $173.37M Reduce
Q2 2026 1.10M $141.03M Reduce
Q3 2026 904.67K $131.46M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MRK and 13F data

MRK (MERCK & CO) is a Health Care company. 30 other funds we track also report a position in MRK — the largest reported positions include BlackRock Inc (US$29.17B), Vanguard Group (US$26.77B), VANGUARD CAPITAL MANAGEMENT LLC (US$23.47B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MRK

All MRK fund holders →

FAQ

How long has ANTIPODES PARTNERS Ltd held MRK?

ANTIPODES PARTNERS Ltd has disclosed MRK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is ANTIPODES PARTNERS Ltd's current position in MRK?

As of Q3 2026, ANTIPODES PARTNERS Ltd holds 904.67K shares of MRK (MERCK & CO), valued at $131.46M, representing 2.42% of its reported portfolio and ranking #13.

Has ANTIPODES PARTNERS Ltd been buying or selling MRK?

In the latest 13F filing (Q3 2026), ANTIPODES PARTNERS Ltd reduced its position in MRK. The position peaked in Q1 2024 at 1.89M shares.

Which other funds hold MRK?

Other major institutional holders of MRK include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.